| Amanda Yant Laubenthal, DO | |
|
3410 Wilmington Rd, New Castle, PA 16105-3210 | |
| (724) 658-7300 | |
| (724) 658-8414 |
| Full Name | Amanda Yant Laubenthal |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 17 Years |
| Location | 3410 Wilmington Rd, New Castle, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235336355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 34.011031 (Ohio) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | OS018507 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Horizon | Greenville, PA | Hospital |
| Upmc Jameson | New castle, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oncology Hematology Association Inc | 9830003300 | 163 |
News Archive
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that two oncology posters are being displayed this week at the Innovations in Cancer Prevention and Research Conference at the Austin Convention Center in Austin, TX.
Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.
Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta (zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment options.
Despite the variety of effective treatments, and physicians who specialize in treating pain, women often suffer unnecessarily from conditions ranging from backaches to pain after cancer surgery, and also treat their pain with medications that may be ineffective and possibly harmful, according to a review of research related to women and pain by the American Society of Anesthesiologists.
Young children with narrow retinal artery diameters were more likely to develop higher blood pressure, and children with higher blood pressure levels were more likely to develop retinal microvascular impairment during early childhood, according to a new study published today in Hypertension, an American Heart Association journal.
› Verified 9 days ago
| Entity Name | Oncology Hematology Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861469223 PECOS PAC ID: 9830003300 Enrollment ID: O20031118000757 |
News Archive
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that two oncology posters are being displayed this week at the Innovations in Cancer Prevention and Research Conference at the Austin Convention Center in Austin, TX.
Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.
Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta (zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment options.
Despite the variety of effective treatments, and physicians who specialize in treating pain, women often suffer unnecessarily from conditions ranging from backaches to pain after cancer surgery, and also treat their pain with medications that may be ineffective and possibly harmful, according to a review of research related to women and pain by the American Society of Anesthesiologists.
Young children with narrow retinal artery diameters were more likely to develop higher blood pressure, and children with higher blood pressure levels were more likely to develop retinal microvascular impairment during early childhood, according to a new study published today in Hypertension, an American Heart Association journal.
› Verified 9 days ago
| Entity Name | Butler Cancer Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649519778 PECOS PAC ID: 7719122316 Enrollment ID: O20130403000115 |
News Archive
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that two oncology posters are being displayed this week at the Innovations in Cancer Prevention and Research Conference at the Austin Convention Center in Austin, TX.
Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.
Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta (zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment options.
Despite the variety of effective treatments, and physicians who specialize in treating pain, women often suffer unnecessarily from conditions ranging from backaches to pain after cancer surgery, and also treat their pain with medications that may be ineffective and possibly harmful, according to a review of research related to women and pain by the American Society of Anesthesiologists.
Young children with narrow retinal artery diameters were more likely to develop higher blood pressure, and children with higher blood pressure levels were more likely to develop retinal microvascular impairment during early childhood, according to a new study published today in Hypertension, an American Heart Association journal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Yant Laubenthal, DO 3410 Wilmington Rd, New Castle, PA 16105-3210 Ph: (724) 658-7300 | Amanda Yant Laubenthal, DO 3410 Wilmington Rd, New Castle, PA 16105-3210 Ph: (724) 658-7300 |
News Archive
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that two oncology posters are being displayed this week at the Innovations in Cancer Prevention and Research Conference at the Austin Convention Center in Austin, TX.
Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.
Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta (zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment options.
Despite the variety of effective treatments, and physicians who specialize in treating pain, women often suffer unnecessarily from conditions ranging from backaches to pain after cancer surgery, and also treat their pain with medications that may be ineffective and possibly harmful, according to a review of research related to women and pain by the American Society of Anesthesiologists.
Young children with narrow retinal artery diameters were more likely to develop higher blood pressure, and children with higher blood pressure levels were more likely to develop retinal microvascular impairment during early childhood, according to a new study published today in Hypertension, an American Heart Association journal.
› Verified 9 days ago
Ankur Panchal, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 Wilmington Ave, Jameson Hospital, New Castle, PA 16105 Phone: 724-656-4264 | |
Dr. Silvia E Coleman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 125 Enclave Dr, New Castle, PA 16105 Phone: 724-658-6656 Fax: 724-658-6542 | |
Sheryl R Simon, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2602 Wilmington Rd, Suite 101, New Castle, PA 16105 Phone: 724-658-7300 Fax: 724-658-8414 | |
Ramesh Kaul, MD, FCCP, MS Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2602 Wilmington Rd, Suite 102, New Castle, PA 16105 Phone: 724-657-5285 Fax: 724-657-6714 | |
Dr. Sandra Milena Pinzon, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2004 W State St, New Castle, PA 16101 Phone: 724-656-4037 | |
Dr. Mohamed K Tejpar, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2602 Wilmington Rd, Suite 208, New Castle, PA 16105 Phone: 724-658-6583 Fax: 724-658-6081 | |
Dr. Kamal Wadhwa, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2602 Wilmington Rd, Suite 200, New Castle, PA 16105 Phone: 724-657-3204 Fax: 724-652-7144 |